Effects of home confinement during COVID-19 outbreak on glycemic control in patients with type 2 diabetes receiving telemedicine support.

Scoccimarro, Daniele; Giove, Gianluca; Silverii, Antonio; Dicembrini, Ilaria; Mannucci, Edoardo

Scoccimarro, Daniele; Giove, Gianluca; Silverii, Antonio; Dicembrini, Ilaria; Mannucci, Edoardo.

Scoccimarro D; University of Florence, Florence, Italy. daniele.scoccimarro@unifi.it.
Giove G; Department of Diabetology, Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50134, Florence, Italy. daniele.scoccimarro@unifi.it.
Silverii A; University of Florence, Florence, Italy.
Dicembrini I; Department of Diabetology, Azienda Ospedaliero-Universitaria Careggi, Largo Brambilla 3, 50134, Florence, Italy.
Mannucci E; University of Florence, Florence, Italy.

Acta Diabetol ; 59(2): 281-284, 2022 02.

Article in English | MEDLINE | ID: covidwho-1513975

Subject(s)

COVID-19; Diabetes Mellitus, Type 2; Telemedicine; Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 2/drug therapy; Diabetes Mellitus, Type 2/epidemiology; Disease Outbreaks; Glycemic Control; Humans; SARS-CoV-2

Keywords

Body weight; HbA1c; Lockdown; Telemedicine; Type 2 diabetes

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Telemedicine / Diabetes Mellitus, Type 2 / COVID-19 Type of study: Experimental Studies / Observational study Limits: Humans Language: English Journal: Acta Diabetol Journal subject: Endocrinology Year: 2022 Document Type: Article Affiliation country: S00592-021-01817-4

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google